Mayor has monumental plan for Georgia Street, delays name change
Indianapolis Mayor Greg Ballard temporarily calls off plans to rename the historic street to instead focus on a project that would line it with 30 monuments saluting famous Hoosiers.
Home » Search
Search Results
4,411 results for '\"eli lilly\"'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
Team-building exercises remain popular, but do they work?
Even in today’s tight economy, the trend of organizing off-site team-building exercises for employees is still going strong.
Company news
Indianapolis-based WellPoint Inc. caught the attention of employers and health benefits brokers with its agreement to buy a stake in Bloom Health, a private health-insurance exchange that would compete for employers with the state-run marketplaces set to open in 2014 as part of the health reform overhaul. According to Bloomberg News, WellPoint and two not-for-profit health insurers will acquire a 78-percent stake in Minneapolis-based Bloom. It is an online marketplace offering a variety of health plans to about 20,000 workers at almost 50 companies. WellPoint officials think a private exchange could offer more consistency for multi-state employers than the state-run exchanges. Under the Bloom model, companies pay employees a fixed amount to cover a portion of their health-care coverage and workers provide the rest based on the plans they select. The idea of the private health-care exchange and its defined contribution model is similar to the trend in retirement benefits in which employers have been abandoning defined benefit pension plans for the relative financial safety of a 401(k) that allows companies to control how much they spend.
With its bestseller Zyprexa losing patent protection next month, Indianapolis-based Eli Lilly and Co. is trying to wring every dollar it can out of its other products, including its $2.2 billion-a-year lung cancer drug Alimta. And Lilly got some good news on that front Monday. A committee at the European Medicines Agency issued a positive opinion for the use of Alimta as a "continuation" maintenance therapy, Lilly announced. That makes market approval by the European Commission more likely. Continuation maintenance approval could mean significantly more dollars for Lilly. It would allow doctors to treat lung cancer patients with Alimta during initial treatment and for numerous months afterward to keep the disease in check. Alimta already was approved as a maintenance drug, but only for use after initial treatment of the disease with other drugs. Receiving approval as a maintenance therapy, which Alimta won back in 2009, helped sales soar 66 percent since then. Alimta sales totaled $1.2 billion worldwide in the first half of 2011. According to Lilly, no chemotherapy is currently approved as a continuation maintenance drug. Alimta is designed to treat patients with non-small cell lung cancer who have a certain tumor type called nonsquamous.
The Conquer Cancer Foundation of the American Society of Clinical Oncology gave $450,000 to Dr. Bryan Schneider, a physician-researcher at the Indiana University Melvin and Bren Simon Cancer Center. Schneider will use the three-year grant to study the neuropathy that some chemotherapy patients develop in hopes of eventually developing treatments to prevent it. Schneider has received three previous awards from the foundation.
Community Health Network opened a Community Spine Center in Greenwood, similar to the original spine center at Community North Hospital in Castleton. The south-side center will be led by Dr. Joshua Salyer, a graduate of Midwestern University-Arizona College of Osteopathic Medicine.
Lilly’s Alimta get favorable opinion for new use in Europe
If approved for continuation maintenance, Eli Lilly and Co.’s Alimta could be used for longer stretches in lung cancer patients, generating more revenue.
Interactive Intelligence hits 1,000-employee mark
The Indianapolis-based software firm said it has added 190 jobs in Indiana since the beginning of 2010—a 46-percent growth rate in its state employment.
Debate rages over whether Lilly’s Byetta lifts cancer risk
A German researcher disputed the validity of a study that found Byetta and another diabetes drug increase cancer risk.
Columbia Club nudges aside one foundation, forms second
The Columbia Club has formed a not-for-profit, the Columbia Club Historic Preservation Foundation, to preserve its 1924 building on Monument Circle. The 28-year-old Columbia Club Foundation already exists for the same purpose, and its fate is now unclear.
Critics: Patent overhaul could hurt startups
When the Senate passed legislation last week overhauling the U.S. patent system, large multinational corporations like Eli Lilly and Co. rejoiced. But small-business advocates cried foul, saying the changes would put innovative startups at a disadvantage.
Health regulatory leaders ready to flock to city
The top event for regulatory professionals in the health care industry is headed to Indianapolis next month. The annual conference of the Regulatory Affairs Professionals Society, or RAPS, is expected to draw thousands of members representing 120 companies and organizations.
Lilly invests $30M in chronic-disease partnerships
Drugmaker Eli Lilly and Co. said Tuesday it will spend $30 million over five years to fight chronic illnesses like heart disease, diabetes, cancer and respiratory disease in developing countries.
Senate passes overhaul of patent system
The legislation would fundamentally alter the way patents are reviewed and mark the biggest change to U.S. patent law since at least 1952.
FDA gets new report on Lilly diabetes drug
Drugmakers Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said Monday that patients taking their potential once-weekly diabetes treatment, Bydureon, saw a significant improvement in cardiovascular risk factors.
People
Managed Health Services has hired Dana Moell as its director of member and provider services. Moell previously served as assistant director of alumni relations at DePauw University in Greencastle. She also served as a customer relations supervisor, manager and reservations general manager with ATA Airlines Inc. Managed Health Services, a subsidiary of St. Louis-based Centene Corp., is a health maintenance organization that has contracts with the Indiana Medicaid program and the Healthy Indiana Plan.
Indiana University Health appointed Eli Lilly and Co. executive Anne Nobles to its board of directors. Nobles is Lilly’s senior vice president for enterprise risk management and chief ethics and compliance officer.
Who’s Who in Health Care and Benefits
Every business sector has influential players, whether they are in the public eye or wield their influence behind the scenes. This month, IBJ zeroes in on Health Care and Benefits.
FDA deal with drugmakers raises user fees 6 percent
Drugmakers including Eli Lilly an Co. have agreed with regulators on a 6-percent increase in review fees as part of reauthorizing the drug-approval process through fiscal 2017.
Butler center aims to make urban farming viable
Tim Carter, director of Butler University’s Center for Urban Ecology, is intent on making CUE a national leader in urban ecology by making the center’s research valuable on a broad scale.
Mayoral foes see different paths to boost business
Both candidates for Indianapolis mayor are touting a host of ways to improve the city’s business climate. Incumbent Greg Ballard champions improving the city’s amenities. Challenger Melina Kennedy focuses on recruiting entrepreneurs to the city.